Literature DB >> 29631730

Exercise-Induced Bronchoconstriction: Background, Prevalence, and Sport Considerations.

Matteo Bonini1, William Silvers2.   

Abstract

The transient airway narrowing that occurs as a result of exercise is defined as exercise-induced bronchoconstriction (EIB). The prevalence of EIB has been reported to be up to 90% in asthmatic patients, reflecting the level of disease control. However, EIB may develop even in subjects without clinical asthma, particularly in children, athletes, patients with atopy or rhinitis, and following respiratory infections. The intensity, duration, and type of training have been associated with the occurrence of EIB. In athletes, EIB seems to be only partly reversible, and exercise seems to be a causative factor of airway inflammation and symptoms.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Asthma; Athlete; Bronchoconstriction; Exercise; Prevalence; Sport discipline

Mesh:

Year:  2018        PMID: 29631730     DOI: 10.1016/j.iac.2018.01.007

Source DB:  PubMed          Journal:  Immunol Allergy Clin North Am        ISSN: 0889-8561            Impact factor:   3.479


  4 in total

1.  High Incidence of Bronchospastic Response to a Stair Climbing Exercise.

Authors:  Tomas Venckunas; Domantas Balsys
Journal:  Cureus       Date:  2021-05-04

2.  Inconsistent calculation methodology for the eucapnic voluntary hyperpnoea test affects the diagnosis of exercise-induced bronchoconstriction.

Authors:  Sarah Koch; Sean Michael Sinden; Michael Stephen Koehle
Journal:  BMJ Open Respir Res       Date:  2018-12-18

Review 3.  Evidence for lifestyle interventions in asthma.

Authors:  Isobel Stoodley; Lily Williams; Cherry Thompson; Hayley Scott; Lisa Wood
Journal:  Breathe (Sheff)       Date:  2019-06

4.  Pediatric Asthma Attack and Home Paint Exposure.

Authors:  Nadia T Saif; Julia M Janecki; Adam Wanner; Andrew A Colin; Naresh Kumar
Journal:  Int J Environ Res Public Health       Date:  2021-04-13       Impact factor: 3.390

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.